StockData
Embecta Corp. logo

Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.25−0.21 (-3.25%)

Close on Nov 16, 2026Market cap $354.12MP/E 4.3Yield 9.60%

Embecta cash

Cash and short-term investments held at the end of each period.

Embecta's cash was $214.70M at Jun 30, 2026. For fiscal 2025 it was $225.50M, down 17.8% from the year before. The highest annual figure on record is $330.90M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025$225.50M-17.8%
FY2024Sep 30, 2024$274.20M-16.0%
FY2023Sep 30, 2023$326.50M-1.3%
FY2022Sep 30, 2022$330.90M–
FY2021Sep 30, 2021$0–
FY2020Sep 30, 2020$0–
FY2019Sep 30, 2019$0–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$214.70M-8.1%
Q2 FY2026CQ1 2026Mar 31, 2026$184.90M-12.9%
Q1 FY2026CQ4 2025Dec 31, 2025$201.30M-7.1%
Q4 FY2025CQ3 2025Sep 30, 2025$225.50M-17.8%
Q3 FY2025CQ2 2025Jun 30, 2025$233.60M-17.1%
Q2 FY2025CQ1 2025Mar 31, 2025$212.30M-30.7%
Q1 FY2025CQ4 2024Dec 31, 2024$216.70M-27.5%
Q4 FY2024CQ3 2024Sep 30, 2024$274.20M-16.0%
Q3 FY2024CQ2 2024Jun 30, 2024$281.80M-11.2%
Q2 FY2024CQ1 2024Mar 31, 2024$306.50M-11.5%
Q1 FY2024CQ4 2023Dec 31, 2023$298.70M-22.5%
Q4 FY2023CQ3 2023Sep 30, 2023$326.50M-1.3%
Q3 FY2023CQ2 2023Jun 30, 2023$317.40M+8.6%
Q2 FY2023CQ1 2023Mar 31, 2023$346.40M+31.1%
Q1 FY2023CQ4 2022Dec 31, 2022$385.20M–
Q4 FY2022CQ3 2022Sep 30, 2022$330.90M–
Q3 FY2022CQ2 2022Jun 30, 2022$292.30M–
Q2 FY2022CQ1 2022Mar 31, 2022$264.30M–
Q1 FY2022CQ4 2021Dec 31, 2021$0–
Q4 FY2021CQ3 2021Sep 30, 2021$0–
Q3 FY2021CQ2 2021Jun 30, 2021$0–
Q2 FY2021CQ1 2021Mar 31, 2021$0–
Q1 FY2021CQ4 2020Dec 31, 2020$0–
Q4 FY2020CQ3 2020Sep 30, 2020$0–
Q4 FY2019CQ3 2019Sep 30, 2019$0–

More Embecta figures

See a number that looks wrong?